This section contains descriptions of current portfolio investments, as well as representative companies from prior investments.

 
 

Bacchus Vascular Inc.
3110 Coronado Drive
Santa Clara, CA 95054
Phone: 408 980 8300
Fax: 408 980 8383

www.bacchus-vascular.com

Bacchus Vascular, Inc. is developing a safe, potentially less invasive, and more effective procedure to percutaneously remove blood clots from dialysis and peripheral grafts as well as native arteries and veins. In addition, the company is looking to develop additional products for de-bulking peripheral, coronary, and carotid vessels.
 

BioLucent, Inc.
27121 Aliso Creek Road, Suite 125
Aliso Viejo, CA 92656
(949) 349-1380

www.biolucent.com

BioLucent, Inc. is dedicated to designing and producing products that improve the mammography experience. The Company's goal is to increase the number of women who benefit from regular recommended mammograms.


DataCore Software Corporation
6261 N.W. 6th Way, Suite 110
Fort Lauderdale, FL 33309-1088
Phone: (954) 267-1620
Fax: (954) 938-7953
www.datacoresoftware.com

DataCore Software Corporation develops storage networking software, which manage and control Storage Area Networking (SAN) infrastructures. Its products virtualize isolated islands of storage into shared storage pools that can then be reallocated and presented to systems as universal storage that is secure and interoperable.
 

Fox Hollow Technologies, Inc.
3355 Edison Way
Menlo Park, CA 94025
Phone: 650 364 4300
Fax: 650 364 9100
www.foxhollowtech.com

Fox Hollow Technologies, Inc. has developed a coronary catheter that facilitates complete coronary lesion de-bulking, which has been shown to significantly reduce restenosis. The company's technology is designed to address the needs of the interventional cardiologist for a process that has traditionally been complex and has not allowed for complete de-bulking.

 

LuMend, Inc.
400 Chesapeake Drive
Redwood City, CA 94063
Phone: 650 364 1400
Fax: 650 556 9968
www.lumend.com

LuMend, Inc. is dedicated to developing, manufacturing and marketing innovative medical devices that meet significant unmet clinical needs in interventional cardiology and radiology. The company's products are designed to enable physicians to safely, predictably and cost-effectively cross chronic total occlusions (CTOs) and allow for subsequent treatment using catheter-based, minimally invasive procedures. Despite the high incidence of CTOs in patients with coronary and peripheral vascular disease, the catheter-based technology options available to treat these patients in a predictable, safe, reliable, and cost-effective manner are limited.

 

Microfabrica Inc.
(formerly MEMGen Corporation)
1103 West Isabel Street
Burbank, CA 91506
Phone: 818-295-3996 x280
Fax: 818-295-3998
www.microfabrica.com

Microfabrica, Inc. is focused on becoming a leading provider of proprietary technology for the manufacturing of high-impact products that incorporate microelectromechanical systems (MEMS).
 

Neoforma.com, Inc.
3061 Zanker Road
San Jose, CA 95134
Phone: 408 468 4000
Fax: 408 468 4040
www.neoforma.com

Neoforma.com, Inc. delivers comprehensive information and e-commerce services for medical products, equipment, supplies, and services to healthcare buyers and suppliers worldwide. Neoforma.com's mission is to make healthcare procurement efficient and cost-effective, so healthcare professionals can spend less time doing business and more time caring for patients.

S-1 Document Filed

 

Novare Surgical Systems, Inc.
10231 Bubb Road
Cupertino, CA 95014
Phone: 408 873 3161
Fax: 408 873 3168
www.novaresurgical.com

Novare Surgical Systems, Inc. develops innovative and cost-effective atraumatic systems that provide surgeons with unmatched confidence in and control of their surgical occlusion. With its uniquely engineered designs, the company aims to expand the surgical temporary occlusion markets of the U.S. and Europe, estimated to be worth up to $155 million each.

 
Novus Packaging Corporation

Novus Packaging Corporation manufactures on site protective packaging systems that are fast, flexible, and easy to use. The Novus system delivers SculptAir TM protective pillows from flat, easy to store rolls that are clean, reusable, recyclable, and flexible for all shipping needs.

NOTE: The company has been acquired by Free Flow Packaging, Inc.

 

Oratec Interventions, Inc.
3700 Haven Court
Menlo Park, CA 94025
Phone: 650 369 9904
Fax: 650 369 9913
www.oratec.com

Oratec Interventions, Inc. is focused on the orthopedic markets of arthroscopic surgery and minimally invasive spine therapies offering curative therapies for patients that might not be candidates for conventional surgery. Oratec's technology is based on the proprietary application of radio frequency and thermal energy for minimally invasive orthopedic interventions. Oratec has received regulatory approval for its devices which have been used in over 70,000 procedures.

S-1 Document Filed

NOTE: The company has been acquired by Smith & Nephew

 

RadioTherapeutics Corporation
1308 Borregas Avenue
Sunnyvale, CA 94089
Phone: 408-745-3200
Fax: 408-745-9848
www.radiotherapeutics.com

RadioTherapeutics Corporation is developing tools for minimally invasive treatment of solid tumors. The RF 2000B is used by surgeons, interventional radiologists, and gastroenterologists to predictably, precisely and homogeneously ablate diseased or unwanted volumes of soft tissues. The RadioTherapeutics ablation system was showcased at the Society of Surgical Oncology and the Society of Cardiovascular and Interventional Radiology meetings in March 1999.

NOTE: The company has been acquired by Boston Scientific Corporation (NYSE: BSX)

 

Securant Technologies, Inc.
1 Embarcadero Center Lobby 5
San Francisco, CA 94111
Phone: 415 315 1500
Fax: 415 315 1545
www.securant.com

Securant Technologies, Inc. is a leading developer of software solutions that provide a solid, integrated security infrastructure for electronic commerce. The company's software enables companies to easily manage a cohesive security policy required when deploying secure electronic commerce applications on the Web or across an Enterprise. It also allows companies to easily move their businesses on-line, to create new revenue opportunities, and to improve efficiency. Securant's software provides the means for companies to administer security for environments where scalability and reliability are mission-critical.

NOTE: The company has been acquired by RSA Security Inc. (NASDAQ: RSAS)

 

Sleep Solutions, Inc.
2450 El Camino Real, Ste.101
Palo Alto, CA  94306
Phone: 650 320 8090
Fax: 650 320 8190
www.sleep-solutions.com

Sleep Solutions®, Inc. (SSI) provides a diagnostic service for home testing and evaluation of Sleep Disordered Breathing, which includes the diagnosis of Obstructive Sleep Apnea (OSA). The service uses proprietary technology designed, manufactured and distributed by Sleep Solutions to accomplish multi-night analysis at a lower cost than traditional sleep lab diagnostic tests. OSA refers to upper airway distress during sleep that restricts or prevents breathing. OSA is a serious and potentially life-threatening sleep disorder that afflicts as many as 18 million Americans of which only 10%-15% have been diagnosed. The U.S. represents approximately half of the worldwide market opportunity for OSA testing.

The diagnostic system that will be provided to and self-administered by patients in their home to provide physicians and their patients a fast, web and fax based, cost effective, accurate and comfortable alternative to in-laboratory sleep studies. The product has been cleared by the FDA for sale in the United States. Commercialization of the diagnostic service began in 2001.

 

Starion Instruments Corporation
20665 Fourth Street
Saratoga, CA 95070
Phone: 408 741 8773
Fax: 408 741 8774
www.starioninstruments.com

Starion Instruments Corporation's technology combines cutting and coagulation in a single surgical instrument to decrease operating time and increase both safety and reliability. The company's devices are either disposable or semi-disposable, allowing maximum flexibility for introduction in ambulatory surgical facilities, physician offices and international markets. Starion's product eliminates the need for the hand-fashioned, multi-step, multi-instrument surgical techniques. The Company received FDA approval and launched its product in October 1999.

 

Vascular Architects, Inc.
1830 Bering Dr.
San Jose, CA 95112
Phone: 877 827 2728
Fax:877 453 7970
www.vasculararchitects.com

Vascular Architects, Inc. develops devices and procedures for the emerging endovascular surgery market. The company is specifically focused on a system approach for the treatment of peripheral vascular occlusive disease, with initial focus being placed on occlusive disease in the iliac and superficial femoral artery.

 

Ventrica, Inc.
5055 Brandin Court
Fremont, CA 94538
Phone: 510 438 7100
Fax: 510 623 7862

Ventrica, Inc. is developing a new generation of heart bypass devices designed to revascularize coronary arteries by shunting blood directly from the left ventricle of the heart and thus tapping into the body's natural source of oxygenated blood. This revolutionary approach has the ability to significantly change the way conventional coronary artery bypass graft surgery is performed.

 

 

 

 
Investment Criteria  Management Team Scientific Advisory Board

Portfolio Companies | Contact Us  Home

 

© 1999-2000 Atherton Venture Partners, LLC